What’s Vulnerable › Vulnerabilities

CVE-2023-33364

• Severity: high (CVSS 8.8 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 1.6% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2023-08-03 · updated 2026-06-17
• Weakness: CWE-78

Description

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Affected products

• supremainc BioStar 2: before 2.9.1 — fixed in 2.9.1

How to fix

Upgrade to a fixed version: supremainc BioStar 2 2.9.1. Check the vendor advisory for mitigations.

References

• https://claroty.com/team82/disclosure-dashboard/cve-2023-33364
• https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291
• https://claroty.com/team82/disclosure-dashboard/cve-2023-33364
• https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291

Get alerted when CVE-2023-33364 or the next vulnerability affects your stack